基于CT的细胞外容积在腹部肿瘤的研究进展
Advances in CT-Based Extracellular Volume in Abdominal Tumors
摘要: 疾病的发生及发展都与其细胞微环境密切相关,而细胞外基质是细胞微环境的重要组成部分,因此对病变细胞外基质的评估对疾病的术后疗效及远期预后有重要意义,能够帮助临床医生制定治疗方案。影像学检查是一种能够无创并定量地评估细胞外基质的一种有效手段。本文将对目前基于CT计算的细胞外容积在腹部肿瘤的应用及研究进展进行综述。
Abstract: Diseases’ occurrence and development are closely related to its cellular microenvironment, and the extracellular matrix (ECM) is an important part of the cellular microenvironment, so the evaluation of the extracellular matrix (ECM) of the lesion is important for the postoperative efficacy and long-term prognosis of the disease, it can help clinicians to formulate a treatment plan. Imaging is an effective tool to assess the extracellular matrix (ECM) non-invasively and quantitatively. In this review, we will summarize the current research progress of extracellular volume (ECV) based on computed tomography (CT) in abdominal tumors.
文章引用:陈良潇, 郭大静. 基于CT的细胞外容积在腹部肿瘤的研究进展[J]. 临床医学进展, 2024, 14(4): 2559-2564. https://doi.org/10.12677/acm.2024.1441328

参考文献

[1] Karamanos, N.K., Theocharis, A.D., Piperigkou, Z., et al. (2021) A Guide to the Composition and Functions of the Extracellular Matrix. The FEBS Journal, 288, 6850-6912. [Google Scholar] [CrossRef] [PubMed]
[2] Wong, T.C., Piehler, K., Meier, C.G., et al. (2012) Association between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality. Circulation, 126, 1206-1216. [Google Scholar] [CrossRef
[3] Anderson, K.R., Sutton, M.G. and Lie, J.T. (1979) Histopathological Types of Cardiac Fibrosis in Myocardial Disease. The Journal of Pathology, 128, 79-85. [Google Scholar] [CrossRef] [PubMed]
[4] Scully, P.R., Bastarrika, G., Moon, J.C., et al. (2018) Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography. Current Cardiology Reports, 20, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[5] Altabella, L., Borrazzo, C., Carnì, M., et al. (2017) A Feasible and Automatic Free Tool for T1 and ECV Mapping. Physica Medica, 33, 47-55. [Google Scholar] [CrossRef] [PubMed]
[6] Treibel, T.A., Fontana, M., Maestrini, V., et al. (2016) Automatic Measurement of the Myocardial Interstitium: Synthetic Extracellular Volume Quantification without Hematocrit Sampling. JACC Cardiovascular Imaging, 9, 54-63. [Google Scholar] [CrossRef] [PubMed]
[7] Bluemke, D.A. and Kawel-Boehm, N. (2016) Can a MR Imaging Scanner Accurately Measure Hematocrit to Determine ECV Fraction? JACC Cardiovascular Imaging, 9, 64-66. [Google Scholar] [CrossRef] [PubMed]
[8] Lee, H.J., Im, D.J., Youn, J.C., et al. (2016) Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-Enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. Radiology, 280, 49-57. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, X., Du, L., Cao, Y., et al. (2024) Comparing Extracellular Volume Fraction with Apparent Diffusion Coefficient for the Characterization of Breast Tumors. European Journal of Radiology, 171, Article ID: 111268. [Google Scholar] [CrossRef] [PubMed]
[10] Bandula, S., White, S.K., Flett, A.S., et al. (2013) Measurement of Myocardial Extracellular Volume Fraction by Using Equilibrium Contrast-Enhanced CT: Validation against Histologic Findings. Radiology, 269, 396-403. [Google Scholar] [CrossRef
[11] Zhou, Y., Geng, D., Su, G.Y., et al. (2022) Extracellular Volume Fraction Derived from Dual-Layer Spectral Detector Computed Tomography for Diagnosing Cervical Lymph Nodes Metastasis in Patients with Papillary Thyroid Cancer: A Preliminary Study. Frontiers in Oncology, 12, Article ID: 851244. [Google Scholar] [CrossRef] [PubMed]
[12] Schelbert, E.B., Sabbah, H.N., Butler, J., et al. (2017) Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics. Circulation Cardiovascular Imaging, 10, e005619. [Google Scholar] [CrossRef
[13] Adams, L.C., Jurmeister, P., Ralla, B., et al. (2019) Assessment of the Extracellular Volume Fraction for the Grading of Clear Cell Renal Cell Carcinoma: First Results and Histopathological Findings. European Radiology, 29, 5832-5843. [Google Scholar] [CrossRef] [PubMed]
[14] 王亚娟, 包磊. 临床病理活检的必要性与病理诊断的局限性[J]. 中国全科医学, 2010, 13(2B): 567-568.
[15] Guo, S.L., Su, L.N., Zhai, Y.N., et al. (2017) The Clinical Value of Hepatic Extracellular Volume Fraction Using Routine Multiphasic Contrast-Enhanced Liver CT for Staging Liver Fibrosis. Clinical Radiology, 72, 242-246. [Google Scholar] [CrossRef] [PubMed]
[16] Engblom, H., Kanski, M., Kopic, S., et al. (2018) Importance of Standardizing Timing of Hematocrit Measurement When Using Cardiovascular Magnetic Resonance to Calculate Myocardial Extracellular Volume (ECV) Based on Pre-and Post-Contrast T1 Mapping. Journal of Cardiovascular Magnetic Resonance, 20, 46. [Google Scholar] [CrossRef] [PubMed]
[17] Shinagawa, Y., Sakamoto, K., Sato, K., et al. (2018) Usefulness of New Subtraction Algorithm in Estimating Degree of Liver Fibrosis by Calculating Extracellular Volume Fraction Obtained from Routine Liver CT Protocol Equilibrium Phase Data: Preliminary Experience. European Journal of Radiology, 103, 99-104. [Google Scholar] [CrossRef] [PubMed]
[18] 崔凤娇, 罗娅红. 基于影像学的腹部病变细胞外容积的研究进展[J]. 放射学实践, 2020, 35(9): 1196-1198.
[19] Pickup, M.W., Mouw, J.K. and Weaver, V.M. (2014) The Extracellular Matrix Modulates the Hallmarks of Cancer. EMBO Reports, 15, 1243-1253. [Google Scholar] [CrossRef] [PubMed]
[20] Erdogan, B. and Webb, D.J. (2017) Cancer-Associated Fibroblasts Modulate Growth Factor Signaling and Extracellular Matrix Remodeling to Regulate Tumor Metastasis. Biochemical Society Transactions, 45, 229-236. [Google Scholar] [CrossRef
[21] Lee, S.W., Kwak, H.S., Kang, M.H., et al. (2018) Fibroblast-Associated Tumour Microenvironment Induces Vascular Structure-Networked Tumouroid. Scientific Reports, 8, Article No. 2365. [Google Scholar] [CrossRef] [PubMed]
[22] Ulyte, A., Katsaros, V.K., Liouta, E., et al. (2016) Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Perfusion Parameters for High-Grade Glioma Patients. Neuroradiology, 58, 1197-1208. [Google Scholar] [CrossRef] [PubMed]
[23] Smyth, E.C., Nilsson, M., Grabsch, H.I., et al. (2020) Gastric Cancer. The Lancet (London, England), 396, 635-648. [Google Scholar] [CrossRef
[24] Nishimuta, Y., Tsurumaru, D., Kai, S., et al. (2023) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced Computed Tomography: Correlation with Histopathological Findings in Gastric Cancer. Japanese Journal of Radiology, 41, 752-759. [Google Scholar] [CrossRef] [PubMed]
[25] Luetkens, J.A., Klein, S., Träber, F., et al. (2018) Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results. Radiology, 288, 748-754. [Google Scholar] [CrossRef] [PubMed]
[26] Yoon, J.H., Lee, J.M., Klotz, E., et al. (2015) Estimation of Hepatic Extracellular Volume Fraction Using Multiphasic Liver Computed Tomography for Hepatic Fibrosis Grading. Investigative Radiology, 50, 290-296. [Google Scholar] [CrossRef
[27] Tago, K., Tsukada, J., Sudo, N., et al. (2022) Comparison between CT Volumetry and Extracellular Volume Fraction Using Liver Dynamic CT for the Predictive Ability of Liver Fibrosis in Patients with Hepatocellular Carcinoma. European Radiology, 32, 7555-7565. [Google Scholar] [CrossRef] [PubMed]
[28] Yaghmai, V. (2022) CT-Derived Extracellular Volume to Predict Post-Hepatectomy Liver Failure: A Simple Approach to a Very Complex Problem. European Radiology, 32, 8527-8528. [Google Scholar] [CrossRef] [PubMed]
[29] Peng, Y., Shen, H., Tang, H., et al. (2022) Nomogram Based on CT-Derived Extracellular Volume for the Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma. European Radiology, 32, 8529-8539. [Google Scholar] [CrossRef] [PubMed]
[30] Mizrahi, J.D., Surana, R., Valle, J.W., et al. (2020) Pancreatic Cancer. The Lancet (London, England), 395, 2008-2020. [Google Scholar] [CrossRef
[31] 虞先濬, 刘亮, 徐华祥, 武春涛, 李浩. 胰腺癌综合诊治指南(2018版) [J]. 临床肝胆病杂志, 2018, 34(10): 2109-2120.
[32] Noid, G., Godfrey, G., Hall, W., et al. (2023) Predicting Treatment Response from Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer. International Journal of Radiation Oncology, Biology, Physics, 115, 803-808. [Google Scholar] [CrossRef] [PubMed]
[33] Fukukura, Y., Kumagae, Y., Higashi, R., et al. (2019) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced Multidetector Computed Tomography as a Prognostic Factor in Unresectable Pancreatic Adenocarcinoma Treated with Chemotherapy. European Radiology, 29, 353-361. [Google Scholar] [CrossRef] [PubMed]
[34] Fukukura, Y., Kumagae, Y., Higashi, R., et al. (2020) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced Dual-Energy CT as a Prognostic Factor in Patients with Stage IV Pancreatic Ductal Adenocarcinoma. European Radiology, 30, 1679-1689. [Google Scholar] [CrossRef] [PubMed]
[35] Fukukura, Y., Kumagae, Y., Higashi, R., et al. (2019) Estimation of Extracellular Volume Fraction with Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients with Stage IV Pancreatic Ductal Adenocarcinoma. Pancreas, 48, 1360-1366. [Google Scholar] [CrossRef
[36] Bezzi, C., Mapelli, P., Presotto, L., et al. (2021) Radiomics in Pancreatic Neuroendocrine Tumors: Methodological Issues and Clinical Significance. European Journal of Nuclear Medicine and Molecular Imaging, 48, 4002-4015. [Google Scholar] [CrossRef] [PubMed]
[37] Iwaya, H., Fukukura, Y., Hashimoto, S., et al. (2021) Prognostic Significance of Extracellular Volume Fraction with Equilibrium Contrast-Enhanced Computed Tomography for Pancreatic Neuroendocrine Neoplasms. Pancreatology, 21, 779-786. [Google Scholar] [CrossRef] [PubMed]
[38] Turajlic, S., Swanton, C. and Boshoff, C. (2018) Kidney Cancer: The Next Decade. The Journal of Experimental Medicine, 215, 2477-2479. [Google Scholar] [CrossRef] [PubMed]
[39] Dagher, J., Delahunt, B., Rioux-Leclercq, N., et al. (2019) Percentage Grade 4 Tumour Predicts Outcome for Clear Cell Renal Cell Carcinoma. Pathology, 51, 349-352. [Google Scholar] [CrossRef] [PubMed]
[40] Peng, Y., Tang, G., Sun, M., et al. (2024) Feasibility of Spectral CT-Derived Extracellular Volume Fraction for Differentiating Aldosterone-Producing from Nonfunctioning Adrenal Nodules. European Radiology, 34, 50-59. [Google Scholar] [CrossRef] [PubMed]
[41] Li, S., Liu, J., Guo, R., et al. (2023) T1 Mapping and Extracellular Volume Fraction Measurement to Evaluate the Poor-Prognosis Factors in Patients with Cervical Squamous Cell Carcinoma. NMR in Biomedicine, 36, E4918. [Google Scholar] [CrossRef] [PubMed]
[42] Li, Q., Bao, J., Zhang, Y., et al. (2023) Predictive Value of CT-Based Extracellular Volume Fraction in the Preoperative Pathologic Grading of Rectal Adenocarcinoma: A Preliminary Study. European Journal of Radiology, 163, Article ID: 110811. [Google Scholar] [CrossRef] [PubMed]
[43] Luo, Y., Liu, L., Liu, D., et al. (2023) Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced CT for the Prediction of the Pathological Complete Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. European Radiology, 33, 4042-4051. [Google Scholar] [CrossRef] [PubMed]
[44] Lin, Y.C., Chuang, W.Y., Wei, F.C., et al. (2020) Peripheral Arterial Disease: The Role of Extracellular Volume Measurements in Lower Limb Muscles with MRI. European Radiology, 30, 3943-3950. [Google Scholar] [CrossRef] [PubMed]